Analyst: Subdued prognosis from Sonova after non-renewal of contract
During the fiscal year 2022/23, Sonova lost a significant client in the US as their contract was not renewed. The prognosis for the coming year will be affected as such, estimates Sydbank analyst
by marketwire, translated by christian radich hoffman
Compared to its Danish hearing aid rivals of Demant and GN, Swiss Sonova reports of a toned-down prognosis for the coming fiscal year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Sonova beats back, regains veterans market shares in April
For subscribers
